Dr. Delphine Loirat, a medical oncologist at the Institut Curie, joins us today to discuss the latest advancements in cancer treatment. The Institut Curie is a renowned center for research and treatment of cancer in France, known for its contributions to oncology and patient care. Dr. Loirat specializes in the treatment of solid tumors, which are cancers that form in tissues such as the skin, lungs, and breasts. Her work involves not only the development of new therapies but also the integration of personalized medicine approaches that tailor treatment to the genetic profile of each patient's tumor. This approach aims to improve outcomes and reduce side effects by targeting the specific molecular characteristics of the cancer. In recent years, there has been significant progress in the field of immunotherapy, a type of treatment that helps the body's immune system fight cancer. Dr. Loirat will speak about how immunotherapy is being used more effectively in combination with other treatments, such as chemotherapy and targeted therapy, to enhance patient responses and survival rates. As part of her discussion, Dr. Loirat will also touch on the importance of clinical trials in advancing cancer care. These trials are essential for testing new treatments and therapies in a controlled environment before they can be approved for widespread use. She will highlight some of the ongoing studies at the Institut Curie and the potential impact they may have on future cancer treatments.